-
EP1954255
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1954255
| EP1954255 - A COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER [Right-click to bookmark this link] | Status | The application has been refused Status updated on 27.08.2010 Database last updated on 14.03.2026 | Most recent event Tooltip | 27.08.2010 | Refusal of application | published on 29.09.2010 [2010/39] | Applicant(s) | For all designated states Farmaleis, S.L. 361, Via Augusta 08017 Barcelona / ES | [2008/33] | Inventor(s) | 01 /
LACASA MAS, Aida 361, Via Augusta (Farmaleis) E-08017 Barcelona / ES | 02 /
LACASA MAS, Diana 361, Via Augusta (Farmaleis) E-08017 Barcelona / ES | 03 /
CUNILL AIXELA, Joan 361, Via Augusta (Farmaleis) E-08017 Barcelona / ES | [2008/33] | Representative(s) | Sugrañes, S.L.P. Calle Provenza 304 08008 Barcelona / ES | [N/P] |
| Former [2008/33] | SUGRANES - VERDONCES - FERREGÜELA 304 Calle Provenza 08008 Barcelona / ES | Application number, filing date | 06806530.9 | 25.10.2006 | [2008/33] | WO2006EP10276 | Priority number, date | ES20050002835 | 18.11.2005 Original published format: ES 200502835 | [2008/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2007057090 | Date: | 24.05.2007 | Language: | EN | [2007/21] | Type: | A1 Application with search report | No.: | EP1954255 | Date: | 13.08.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.05.2007 takes the place of the publication of the European patent application. | [2008/33] | Search report(s) | International search report - published on: | EP | 24.05.2007 | Classification | IPC: | A61K31/01, A61K31/202, A61K31/685, A61P35/00 | [2008/33] | CPC: |
A61K31/01 (EP,ES,US);
A61K31/202 (EP,US);
A61K31/685 (EP,US);
A61P35/00 (EP)
| C-Set: |
A61K31/01, A61K2300/00 (EP,US);
A61K31/202, A61K2300/00 (US,EP);
A61K31/685, A61K2300/00 (US,EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/33] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | RS | Not yet paid | Title | German: | KOMBINATION AUS SQUALEN, EINEM PHOSPHOLIPID UND EINER OMEGA-3-FETTSÄURE ZUR BEHANDLUNG VON KREBS | [2008/33] | English: | A COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER | [2008/33] | French: | COMBINAISON COMPRENANT SQUALENE, PHOSPHOLIPIDE ET ACIDE GRAS OMEGA 3, POUR LE TRAITEMENT DU CANCER | [2008/33] | Entry into regional phase | 04.06.2008 | National basic fee paid | 04.06.2008 | Designation fee(s) paid | 04.06.2008 | Examination fee paid | Examination procedure | 04.06.2008 | Examination requested [2008/33] | 21.01.2009 | Despatch of a communication from the examining division (Time limit: M06) | 10.07.2009 | Reply to a communication from the examining division | 15.03.2010 | Application refused, date of legal effect [2010/39] | 15.03.2010 | Date of oral proceedings | 01.04.2010 | Minutes of oral proceedings despatched | 12.05.2010 | Despatch of communication that the application is refused, reason: substantive examination [2010/39] | Fees paid | Renewal fee | 04.06.2008 | Renewal fee patent year 03 | 28.09.2009 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X] JPH04169525 | [X] JPH04169524 | [X] DATABASE WPI Week 199231, Derwent World Patents Index; AN 1992-253494, XP002416753 [X] 1,4,14 * abstract * | [X] DATABASE WPI Week 199231, Derwent World Patents Index; AN 1992-253493, XP002416754 [X] 1,4,14 * abstract * | [X] ROUDEBUSH PHILIP ET AL: "The use of nutraceuticals in cancer therapy.", VETERINARY CLINICS OF NORTH AMERICA SMALL ANIMAL PRACTICE, vol. 34, no. 1, January 2004 (2004-01-01), pages 249 - 269, XP009077637, ISSN: 0195-5616 [X] 1-16 * page 256, paragraph L - page 262, paragraph 3 * DOI: http://dx.doi.org/10.1016/j.cvsm.2003.09.001 | [X] BIAGI G ET AL: "The role of dietary omega-3 and omega-6 essential fatty acids in the nutrition of dogs and cats: A review", PROGRESS IN NUTRITION 2004 ITALY, vol. 6, no. 2, 2004, pages 97 - 107, XP009077635, ISSN: 1129-8723 [X] 1-16 * page 104, paragraph L - page 105, paragraph 1 * | [X] OGILVIE G K: "Interventional nutrition for the cancer patient", CLINICAL TECHNIQUES IN SMALL ANIMAL PRACTICE, SAUNDERS, PHILADELPHIA, PA, US, vol. 13, no. 4, November 1998 (1998-11-01), pages 224 - 231, XP004969113, ISSN: 1096-2867 [X] 1-16 * page 226, column 1, paragraph 1 - paragraph 2 * DOI: http://dx.doi.org/10.1016/S1096-2867(98)80007-8 | [X] OGILVIE G K ET AL: "EFFECT OF FISH OIL, ARGININE, AND DOXORUBICIN CHEMOTHERAPY ON REMISSION AND SURVIVAL TIME FOR DOGS WITH LYMPHOMA A DOUBLE-BLIND, RANDOMIZED PLACEBO-CONTROLLED STUDY", CANCER, AMERICAN CANCER SOCIETY, PHILADELPHIA, PA, US, vol. 88, no. 8, 15 April 2000 (2000-04-15), pages 1916 - 1928, XP001181907, ISSN: 0008-543X [X] 1-16 * page 1926, column 1, paragraph 2 * DOI: http://dx.doi.org/10.1002/(SICI)1097-0142(20000415)88:8<1916::AID-CNCR22>3.0.CO;2-F | [X] NEWMARK HAROLD L: "Squalene, olive oil, and cancer risk: A review and hypothesis", CANCER EPIDEMIOLOGY BIOMARKERS AND PREVENTION, vol. 6, no. 12, December 1997 (1997-12-01), pages 1101 - 1103, XP002416703, ISSN: 1055-9965 [X] 1-16 * paragraph [000L] * | [X] SMITH T J: "Squalene: Potential chemopreventive agent", EXPERT OPINION ON INVESTIGATIONAL DRUGS 2000 UNITED KINGDOM, vol. 9, no. 8, 2000, pages 1841 - 1848, XP007901603, ISSN: 1354-3784 [X] 1-16 * the whole document * DOI: http://dx.doi.org/10.1517/13543784.9.8.1841 |